|Bid||369.29 x 800|
|Ask||370.00 x 1200|
|Day's Range||355.16 - 369.98|
|52 Week Range||335.68 - 555.77|
|Beta (5Y Monthly)||0.89|
|PE Ratio (TTM)||60.47|
|Earnings Date||Feb 09, 2022 - Feb 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||437.13|
Subscribe to Yahoo Finance Plus to view Fair Value for ILMNLearn more
Companies in the so-called "liquid biopsy" space, heavily focused on the Bay Area, have raised billions of dollars to try to detect cancer early.
MENLO PARK, Calif., December 06, 2021--GRAIL announces partnership with Alignment Health Plan as first Medicare Advantage Plan to offer Galleri® multi-cancer early detection blood test.
Illumina (NASDAQ:ILMN) has had a rough three months with its share price down 26%. However, stock prices are usually...